The cancer diagnostic firm Caris Life Sciences is set to list on the NASDAQ today. The company actually priced its IPO at $21 a share. That was above its expected range.Joining us right now is David Dean Halbert. He is Caris Life Scienc's founder, chairman, and CEO. And David, welcome.Thank you, Becky. Uh let's talk a little bit about what your company does because it's really interesting AI using life sciences to try and go after identify tumors and and find unique ways to deal with each of those cancer tu ...